CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
1. CVS CEO defends PBMs amidst criticism from lawmakers and drugmakers. 2. PBMs, including CVS Caremark, administer 80% of U.S. prescriptions. 3. Joyner blames drug manufacturers for high prices, not PBMs. 4. Pharmaceutical industry accuses PBMs of inflating costs and pocketing savings. 5. Rising health-care costs are straining patients and providers.